Detlev Riesner

Description

Prof. Riesner has held the Chair of Biophysics at the Heinrich-Heine-University in Düsseldorf, Germany since 1980 and is Director of Technol...

Investor Profile

Detlev Riesner has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

Seed (100%)

Country Focus

Germany (100%)

Industry Focus

Biotechnology
Pharmaceutical
Manufacturing
Health Care
Therapeutics

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Detlev Riesner frequently co-invest with?

European Investment Fund

Europe, Luxembourg, Luxembourg, Luxembourg

Co-Investments: 1

HTGF | High-Tech Gruenderfonds

Europe, Nordrhein-Westfalen, Germany, Bonn

Co-Investments: 2

Evonik Venture Capital

Europe, Hessen, Germany, Hanau

Co-Investments: 1

Which angels does Detlev Riesner often collaborate with?

Jürgen Schumacher

Shared Deals: 1

What are some of recent deals done by Detlev Riesner?

Pantherna Therapeutics

Hennigsdorf, Brandenburg, Germany

Pantherna Therapeutics is a privately-held biopharmaceutical company.

BiotechnologyHealth CarePharmaceuticalTherapeutics

SeedJul 3, 2019

Amount Raised: $3,950,976

Numaferm

Düsseldorf, Nordrhein-Westfalen, Germany

Numaferm is a Dusseldorf University spin-off that specializes in the biotechnical production.

BiotechnologyManufacturingPharmaceutical

SeedMay 13, 2017